← All companies

HRGN

Harvard Apparatus Regenerative Technology Inc.

HRGN OTC Surgical & Medical Instruments & Apparatus EDGAR ↗

$1.00

-0.04 -3.85%

Key statistics

from XBRL data in SEC filings

Market cap

$17.6M

Revenue (TTM)

$885K

Net income (TTM)

-$6.81M

EPS (TTM)

$-0.41

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$419K

Total assets

$1.80M

Gross margin

—

52-week range

$0.96 – $2.22

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Took on a direct financial obligation Aug 3, 2026 8-K/A Entered a material agreement; Took on a direct financial obligation Aug 3, 2026 8-K Shareholder vote results Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Regulation FD disclosure Apr 28, 2026 8-K Terminated a material agreement Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 14, 2025 8-K Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Changed accountants Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement Nov 6, 2024 8-K Director or officer change Aug 27, 2024 8-K Entered a material agreement; Unregistered sale of equity Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Shareholder vote results Jun 24, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Entered a material agreement; Unregistered sale of equity Apr 17, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Entered a material agreement; Took on a direct financial obligation Feb 6, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Amended charter or bylaws; Other events Jul 20, 2023 8-K Shareholder vote results Jul 19, 2023 8-K/A Unregistered sale of equity; Director or officer change Jul 10, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Director or officer change Apr 10, 2023 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 6, 2023 10-K Fiscal year ended 2022-12-31 Mar 30, 2023 8-K Unregistered sale of equity; Director or officer change Mar 14, 2023 8-K Entered a material agreement; Director or officer change; Other events Mar 7, 2023 8-K Unregistered sale of equity; Director or officer change Jan 26, 2023 8-K Unregistered sale of equity; Director or officer change Jan 12, 2023 8-K Other events Dec 28, 2022 8-K Other events Dec 23, 2022